Bordeaux-Based eDevice SA to Assume Commercialization of Innovative TwoCan PulseTM Telecardiology Monitoring System
Summary
MERIGNAC, France--(BUSINESS WIRE)--eDevice SA, a health technology company focused on telemedicine and remote patient monitoring solutions, announced today that it has taken over the commercialization of TwoCan PulseTM, an innovative telecardiology monitoring system, from Boston Scientific. “ Since the beginning, eDevice has been the developer of this innovation in the French market and we wish the team well on the continued success of TwoCan PulseTM,” François Birard, business unit manager of Boston Scientific in France, said. Created under the guidance of premier cardiologists, TwoCan PulseTM was a collaborative development between Boston Scientific and eDevice aimed at advancing telecardiology and has been deployed in France since launching in February 2018. TwoCan PulseTM, composed of a home monitor, medical peripherals, a smart algorithm, and a web application, was specifically designed to allow cardiologists to remotely monitor patients who exhibit symptoms of potential congestive heart failure. The company is the chosen connectivity partner for Medical Devices companies such as Medtronic, Honeywell, Philips, and a technology provider for healthcare participants committed to delivering care virtually and remotely.